JTCS Tips for Better Browsing
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ely, S. W.
Right arrow Articles by Berne, R. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ely, S. W.
Right arrow Articles by Berne, R. M.

The Journal of Thoracic and Cardiovascular Surgery, Vol 90, 549-556, Copyright © 1985 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Functional and metabolic evidence of enhanced myocardial tolerance to ischemia and reperfusion with adenosine

SW Ely, RM Mentzer Jr, RD Lasley, BK Lee and RM Berne

An isolated, isovolumetrically contracting rat heart preparation, perfused at constant flow, was used to test the hypothesis that adenosine treatment (100 microM) throughout the experiment could enhance the repletion of adenosine triphosphate and the recovery of ventricular function following 10 minutes of global, normothermic (37 degrees C) ischemia. Left ventricular developed pressure was measured with an intraventricular balloon, and myocardial adenine nucleotides were measured from freeze-clamped tissues in a parallel series of experiments. The adenosine triphosphate level in the adenosine-treated hearts was not different from that of the untreated control hearts at the end of 30 minutes of equilibration but was significantly (p less than 0.05) higher at the end of 10 minutes of ischemia and at 15, 30, and 60 minutes of reperfusion. Left ventricular developed pressure in the adenosine-treated group at the end of 30 minutes of equilibration (92 +/- 3 mm Hg) was not significantly different from that of the control hearts (101 +/- 10 mm Hg). During the reperfusion period the control group returned to 75% +/- 7%, 73% +/- 6%, and 73% +/- 6% of the preischemic control function at 15, 30, and 60 minutes of reperfusion, respectively. The adenosine-treated group had significantly greater return of function to 86% +/- 3%, 96% +/- 3%, and 95% +/- 3% of the preischemic control at 15, 30, and 60 minutes of reperfusion, respectively. In a protocol to assess the effect of adenosine during ischemia, we found that adenosine (100 microM) increased the time to onset of ischemic contracture by 50% from 12 +/- 3 to 18 +/- 3 minutes and decreased the rate of net adenosine triphosphate degradation. Our data suggest that under these experimental conditions, adenosine enhances myocardial preservation by reducing the net degradation of adenosine triphosphate during ischemia and facilitating the repletion of adenosine triphosphate during reperfusion.


This article has been cited by other articles:


Home page
Exp PhysiolHome page
M. E. Reichelt, L. Willems, J. N. Peart, K. J. Ashton, G. P. Matherne, M. R. Blackburn, and J. P. Headrick
Heart/Cardiac Muscle: Modulation of ischaemic contracture in mouse hearts: a 'supraphysiological' response to adenosine
Exp Physiol, January 1, 2007; 92(1): 175 - 185.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Zhang, D. E. Handy, and J. Loscalzo
Adenosine-Dependent Induction of Glutathione Peroxidase 1 in Human Primary Endothelial Cells and Protection Against Oxidative Stress
Circ. Res., April 29, 2005; 96(8): 831 - 837.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
J. D. Tune, M. W. Gorman, and E. O. Feigl
Matching coronary blood flow to myocardial oxygen consumption
J Appl Physiol, July 1, 2004; 97(1): 404 - 415.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. R. Tracey, W. P. Magee, J. J. Oleynek, R. J. Hill, A. H. Smith, D. M. Flynn, and D. R. Knight
Novel N6-substituted adenosine 5'-N-methyluronamides with high selectivity for human adenosine A3 receptors reduce ischemic myocardial injury
Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2780 - H2787.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
A. Sola, J. Panes, C. Xaus, and G. Hotter
Fructose-1,6-biphosphate and nucleoside pool modifications prevent neutrophil accumulation in the reperfused intestine
J. Leukoc. Biol., January 1, 2003; 73(1): 74 - 81.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, R. Lasley, E. Kilpatrick, P. Narayan, and R. Mentzer Jr.
Apparent Activation of Cardiovascular A1 Adenosine Receptors by A3 Agonists
Am J Physiol Heart Circ Physiol, February 1, 2002; 282 (2): H793 - H796.
[Full Text] [PDF]


Home page
FASEB J.Home page
C. Dougherty, J. Barucha, P. R. Schofield, K. A. Jacobson, and B. T. Liang
Cardiac myocytes rendered ischemia resistant by expressing the human adenosine A1 or A3 receptor
FASEB J, December 1, 1998; 12(15): 1785 - 1792.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
W.R. Tracey, W. Magee, H. Masamune, J. J. Oleynek, and R. J. Hill
Selective activation of adenosine A3 receptors with N6-(3-chlorobenzyl)-5'-N-methylcarboxamidoadenosine (CB-MECA) provides cardioprotection via KATP channel activation
Cardiovasc Res, October 1, 1998; 40(1): 138 - 145.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Minamino, M. Kitakaze, H. Sato, H. Funaya, Y. Ueda, H. Asanuma, T. Kuzuya, and M. Hori
Effects of ischemic preconditioning on contractile and metabolic function during hypoperfusion in dogs
Am J Physiol Heart Circ Physiol, February 1, 1998; 274(2): H684 - H693.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Barankiewicz, A. M. Danks, E. Abushanab, L. Makings, T. Wiemann, R. A. Wallis, P. V. P. Pragnacharyulu, A. Fox, and P. J. Marangos
Regulation of Adenosine Concentration and Cytoprotective Effects of Novel Reversible Adenosine Deaminase Inhibitors
J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1230 - 1238.
[Abstract] [Full Text]


Home page
VASC ENDOVASCULAR SURGHome page
M. M. Farooq, J. A. Freischlag, B. T. Carlsen, R. A. Cambria, G. R. Seabrook, and J. B. Towne
Intraarterial Adenosine Administered During Reperfusion Preserves Endothelium-Dependent Relaxation in the Rabbit Hindlimb
Vascular and Endovascular Surgery, November 1, 1997; 31(6): 713 - 719.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. Sekili, M. O. Jeroudi, X.-L. Tang, M. Zughaib, J.-Z. Sun, and R. Bolli
Effect of Adenosine on Myocardial `Stunning' in the Dog
Circ. Res., January 1, 1995; 76(1): 82 - 94.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. S. Abd-Elfattah, M. E. Jessen, and A. S. Wechsler
Nucleoside trapping during reperfusion prevents ventricular dysfunction, "stunning," in absence of adenosine: Possible separation between ischemic and reperfusion injury" in absence of adenosinePossible separation between ischemic and reperfusion injury
J. Thorac. Cardiovasc. Surg., August 1, 1994; 108(2): 269 - 278.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J. A. Herold, I. L. Kron, S. E. Langenburg, L. H. Blackbourne, and C. G. Tribble
Complete prevention of postischemic spinal cord injury by means of regional infusion with hypothermic saline and adenosine
J. Thorac. Cardiovasc. Surg., February 1, 1994; 107(2): 536 - 542.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1985 by The American Association for Thoracic Surgery.